BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, (NorthStar) a company involved in the production and distribution of radioisotopes used for medical imaging, today announced that ...
Tackling supply shortages: As the supply chain for medical radioisotopes continues to struggle, researchers are developing new methods for producing technetium-99m, and exploring the potential of ...
BELOIT, Wis.--(BUSINESS WIRE)-- NorthStar Medical Radioisotopes, LLC, (NorthStar) a company involved in the production and distribution of radioisotopes used for medical imaging, today announced that ...
ATLANTA, GA--(Marketwired - January 21, 2015) - Perma-Fix Environmental Services, Inc. (PESI), today announced that a consortium led by Perma-Fix Medical, a subsidiary of the company, received an ...
− Concentrated molybdenum-98 (cMo-98) enables up to four-fold increase of critical medical radioisotope Mo-99 production in U.S. – BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, ...
− Collaboration enables integrating technology expertise to provide Tc-99m Generation Systems (TCM Generation Systems) that utilize non-uranium based Mo-99 produced using electron beam accelerators − ...
Radionuclide production is a crucial component in nuclear imaging and therapeutic modalities. More than 90% of its production is used for diagnostic purposes. The majority of the radionuclides are ...
The technetium-99m market is expected to reach US$6.29 billion by 2031 from US$ 4.61 billion in 2024; it is anticipated to register a CAGR of 3.9% during the forecast period. Technetium-99m (Tc-99m) ...
NorthStar Medical Radioisotopes, a privately-held Wisconsin company, announced today that the FDA and the Nuclear Regulatory Commission (NRC) approved the company’s RadioGenix System for producing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback